Antibodies to GAD65 epitopes at diagnosis and over the first 10 years of clinical type 1 diabetes mellitus

Scandinavian Journal of Immunology

Volumn 59, Issue 3, 2004, Pages 334-340

  Ronkainen, M S ^a,b   Savola, K ^a   Knip, M ^b,c,d  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET CELL; PRIORITY JOURNAL;

ADOLESCENT; ANTIBODIES; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A, GLYCOSYLATED; HLA-DR ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; INFANT; INSULIN; ISOENZYMES; LONGITUDINAL STUDIES; MALE;

EID: 1842452699     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01402.x     Document Type: Article

References (27)

1. Schranz DB, Lernmark Å. Immunology in diabetes: an update. Diabetes Metab Rev 1998;14:3-29.
2. Seissler J, Amann J, Mauch L et al. Prevalence of autoantibodies to the 65-and 67-kD isoforms of glumate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1993;92:1394-9.
3. Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M. Autoantibodies associated with type I diabetes mellitus persist after diagnosis in children. Diabetologia 1998;41:1293-7.
4. Borg H, Marcus C, Sjöblad S, Fernlund P, Sundkvist G. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes. Acta Paediatr 2000;89:46-51.
5. Batstra M, Pina M, Quan J et al. Fluctuations in GAD65 antibodies after clinical diagnosis of IDDM in young children. Diabetes Care 1997;20:642-4.
6. Karlsen AE, Hagopian WA, Grubin CE et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci U S A 1991;88:8337-41.
7. Bu DF, Erlander MG, Hitz BC et al. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci U S A 1992;89:2115-9.
8. Erdö SL, Wolff JR. γ-aminobutyric acid outside the mammalian brain. J Neurochem 1990;54:363-72.
9. Karlsen AE, Hagopian WA, Petersen JS et al. Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies. Diabetes 1992;41:1355-9.
10. Hagopian WA, Michelsen B, Karlsen AE et al. Autoantibodies in IDDM primarily recognize the 65,000-Mr isoform of glutamic acid decarboxylase rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 1993;42:631-6.
11. Grubin CE, Daniels T, Toivola B et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994;37:344-50.
12. Vandewalle CL, Falorni A, Svanholm S et al. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 1995;80:846-51.
13. Ujihara N, Daw K, Gianani R, Boel E, Yu L, Powers AC. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type 1 diabetes. Diabetes 1994;43:968-75.
14. Daw K, Powers AC. Two distinct glutamic acid decarboxylase autoantibody specificities in IDDM target different epitopes. Diabetes 1995;44:216-20.
15. Bonifacio E, Lampasona V, Bernasconi L, Ziegler AG. Maturation of the humoral response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes 2000;49:202-8.
16. 2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 1993;180:595-606.
17. Richter W, Shi Y, Baekkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci U S A 1993;90: 2832-6.
18. Syren K, Lindsay L, Stoehrer B et al. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol 1996;157:5208-14.
19. Schwartz HL, Chandonia JM, Kash SF et al. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 1999;287:983-99.
20. Bingley PJ, Bonifacio E, Mueller PW, Participating Laboratories. Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 2003;52:1128-36.
21. Falorni A, Ackefors M, Carlberg C et al. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia 1996; 39:1091-8.
22. Söhnlein P, Müller M, Syren K et al. Epitope spreading and a varying but not disease-specific GAD65 antibody response in type I diabetes. Diabetologia 2000;43:210-7.
23. Hampe CS, Hammerle LP, Bekris L, Örtqvist E, Persson B, Lernmark Å. Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset. J Autoimmun 2002; 18:49-53.
24. Landin-Olsson M, Arnqvist HJ, Blohme G et al. Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus. Autoimmunity 1999;29:57-63.
25. Falorni A, Gambelunghe G, Forini F et al. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab 2000;85:309-16.
26. Borg H, Gottsäter A, Landin-Olsson M, Fernlund P, Sundkvist G. High levels of antigen-specific islet antibodies predict future β-cell failure in patients with onset of diabetes in adult age. J Clin Endocrinol Metab 2001;86:3032-8.
27. Hampe CS, Hammerle LP, Bekris L et al. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody positive phenotypes. J Clin Endocrinol Metab 2000;85: 4671-9.